close

Enter

Log in using OpenID

Pulmonary Arterial Hypertension (PAH) Market

embed
PULMONARY ARTERIAL HYPERTENSION (PAH) MARKET – GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2016–2024
Pulmonary Arterial Hypertension (PAH)
MarketGLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2016-2025
© Coherent market Insights. All Rights Reserved
Pulmonary Arterial Hypertension (PAH) Market Overview :
Pulmonary hypertension or PH is a condition in which the blood pressure rises in the pulmonary artery, vein, or capillaries
(collectively known as lung vasculature), which might lead to shortness of breath, fainting, leg swelling, and dizziness,
among others. Pulmonary hypertension may be a relentless disease with a noticeable reduction in exercise tolerance.
Pulmonary arterial hypertension or PAH indicates that the patient has high blood pressure in arteries that carry blood from
the heart to the lungs. With PAH, the arteries in the lungs become thin or get blocked resulting into irregular blood flow.
Since the flow of blood is hindered, it becomes hard for the blood to flow evenly thereby, increasing the blood pressure in
the patient. In layman terms, it means that the heart works harder to pump blood. It may lead to weakening of the heart
muscles after a certain period of time. Ultimately, pulmonary arterial hypertension may cause heart failure.
Based on the reports gathered from a variety of sources, including CDC (Centers for Disease Control and Prevention) and
WHO (World Health Organization), the global prevalence of pulmonary arterial hypertension is projected to be 100,000 –
200,000, that is about 15 - 50 patients per million of the population. Even though, the treatment available for pulmonary
arterial hypertension is rather limited, various treatment options are available to decrease symptoms, slow down disease
progression, and improve the quality of life. Endothelin receptor antagonists or ERAs, phosphodiesterase-5 (PDE-5)
inhibitors and Prostacyclin and prostacyclin analogs are some of the widely prescribed drug classes used for treatment of
the disease. Lately, a new drug class known as the soluble guanylate cyclase or sGC stimulators has been recognized to
be effective in treating people with PAH.
© Coherent market Insights. All Rights Reserved
Pulmonary Arterial Hypertension (PAH) Market Taxonomy
On the basis of drug class, the global pulmonary arterial hypertension market is classified into:
ERA
Prostacyclin and Prostacyclin Analogs
sGC Stimulators
PDE-5 Dipsticks
On the basis of application, the global pulmonary arterial hypertension market is classified into:
Hospitals
Clinics
Others
Growing prevalence of cardiac diseases to drive growth of the overall pulmonary arterial hypertension (PAH) market
Owing to the sedentary lifestyles, growing consumption of fast food, and lack of exercise, the global numbers for the patients
with cardiac diseases is expected to rise substantially over the forecast period thereby, increasing the susceptibility of
pulmonary arterial hypertension among the global population. This would propel the overall growth of the PAH market in the
near future.
Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/203
© Coherent market Insights. All Rights Reserved
Some of the major companies operating in the pulmonary arterial hypertension (PAH) market in
the current scenario are :
●
Actelion Pharmaceuticals,
●
Ltd.,
●
Gilead Sciences,
●
Inc.,
●
United Therapeutics Corporation,
●
Bayer HealthCare,
●
Pfizer,
●
Novartis International AG
●
GlaxoSmithKline plc.
Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/203
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting
organization focused on assisting its plethora of clients achieve transformational
growth by helping them make critical business decisions. We are headquartered in
India, with an office at the global financial capital in the U.S. Our client base
includes players from across all business verticals in over 150 countries worldwide.
We are uniquely positioned to help businesses around the globe deliver practical
and lasting results through various recommendations about operational
improvements, technologies, emerging market trends and new working methods.
We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We
meticulously study emerging trends across various industries at both the global
and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
© Coherent market Insights. All Rights Reserved
SYNDICATED RESEARCH
COUNTRY SPECIFIC
STUDIES
ABOUT COHERENT MARKET INSIGHTS
Industries we cater
SECTOR COVERAGE
Healthcare
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
Chemicals & Materials
Bulk Chemicals
Advanced Materials
Speciality and Fine
Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic
Ingredients
Polymers &
Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEAR
CH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved
Author
pranali
pranali112   documents Email
Document
Category
Health and Medicine
Views
6
File Size
1 116 KB
Tags
Pulmonary Arterial Hypertension (PAH) Market, market
1/--pages
Report inappropriate content